Skip to main content
T

TeleDaaS

TeleDaaS provides Dosimetry-as-a-Service, utilizing precision-based dosimetry analysis to create tailored treatment plans for cancer patients. The platform enhances clinical trial efficiency and patient outcomes by ensuring accurate dosing, which has been shown to significantly improve life expectancy and increase the number of patients eligible for curative surgery.

Evanston, United StatesFounded 20233100+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Accurate dosimetry is critical for effective cancer treatment with Y90, yet traditional methods can be time-consuming and may not always result in optimized, personalized treatment plans. This can lead to suboptimal dosing, potentially reducing survival rates and limiting the number of patients eligible for curative surgery. Furthermore, many facilities may lack the resources or expertise to ensure consistently accurate dosimetry, impacting patient outcomes and revenue.

Solution

TeleDaaS provides a Dosimetry-as-a-Service (DaaS) platform that leverages precision-based dosimetry analysis to create tailored Y90 treatment plans for cancer patients. The cloud-based service integrates with existing hospital IT infrastructure, streamlining the dosimetry planning process and reducing physician time per case. By ensuring accurate dosing, TeleDaaS aims to improve patient outcomes, increase eligibility for curative surgery, and maximize reimbursement for healthcare providers. The platform offers access to world-class physicians and consultations, providing comprehensive documentation for complete billing and adherence to the highest standards of care.

Target Audience

The primary customers are hospitals, clinics, and research institutions that treat cancer patients with Y90 radioembolization, specifically interventional radiologists, nuclear medicine physicians, and radiation oncologists.

Features

  • Cloud-based dosimetry planning service accessible 24/7
  • Streamlined workflow reducing physician time by 1-2 hours per case
  • Personalized dosimetry analysis to optimize Y90 treatment plans
  • Integration with existing hospital IT systems, eliminating on-premise installation
  • Comprehensive documentation to ensure full and accurate billing
  • Access to expert physicians and consultations
This profile is AI-generated and may contain inaccuracies.